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PDZ Proteins Interacting with C-Terminal GluR2/3
Are Involved in a PKC-Dependent Regulation
of AMPA Receptors at Hippocampal Synapses
subunit is of particular importance because it undergoes
posttranscriptional editing in the pore-forming region at
the so-called Q/R site (Hollmann and Heinemann, 1994),
which leads to AMPAR complexes containing edited
GluR2 subunits exhibiting low permeability to Ca21. The
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vast majority of AMPARs in the postnatal CNS are imper-Department of Anatomy
meable to Ca21 because they contain edited GluR2University of Bristol
(Jonas et al., 1994; Geiger et al., 1995). GluR2 is highlyUniversity Walk
regulated, and disruption in the cellular control of thisBristol BS8 1TD
subunit has been shown to cause altered synaptic plas-United Kingdom
ticity and neurotoxicity (Jia et al., 1996; Feldmeyer et
al., 1999).
Recent studies using the yeast two-hybrid techniqueSummary
have identified a number of proteins that interact with
the C-terminal regions of GluR2 and GluR3 (BraithwaiteWe investigated the role of PDZ proteins (GRIP, ABP,
et al., 2000). Two distinct interaction domains on theand PICK1) interacting with the C-terminal GluR2 by
C-terminal of GluR2 (ct-GluR2) have so far been identi-infusing a ct-GluR2 peptide (“pep2-SVKI”) into CA1
fied, an NSF binding site between residues 844 and 853pyramidal neurons in hippocampal slices using whole-
(Nishimune et al., 1998; Osten et al., 1998; Song et al.,cell recordings. Pep2-SVKI, but not a control or PICK1
1998) and an extreme ct-PDZ binding motif (ct-GluR2/selective peptide, caused AMPAR-mediated EPSC
3 PDZ; Dong et al., 1997; Srivastava et al., 1998; Dev etamplitude to increase in approximately one-third of
al., 1999; Xia et al., 1999). The PDZ binding motif hascontrol neurons and in most neurons following the
been shown to interact with three PDZ domain-con-prior induction of LTD. Pep2-SVKI also blocked LTD;
taining proteins: GRIP (Dong et al., 1997) and ABP (onehowever, this occurred in all neurons. A PKC inhibitor
splice form is also known as GRIP2 [Srivastava et al.,prevented these effects of pep2-SVKI on synaptic trans-
1998; Bru¨ckner et al., 1999]), which are closely relatedmission and LTD. We propose a model in which the
(Srivastava et al., 1998; Bru¨ckner et al., 1999; Braithwaitemaintenance of LTD involves the binding of AMPARs
et al., 2000), and PICK1 (Dev et al., 1999; Xia et al., 1999).to PDZ proteins to prevent their reinsertion. We also
Although the functional consequences of the GluR2-present evidence that PKC regulates AMPAR reinser-
NSF interaction have received considerable attentiontion during dedepression.
(Nishimune et al., 1998; Song et al., 1998; Lu¨scher et
al., 1999; Lu¨thi et al., 1999; Noel et al., 1999), only re-Introduction
cently has progress been made in understanding the
functional roles of the PDZ interactions (Li et al., 1999;
The majority of fast excitatory synaptic transmission
Chung et al., 2000; Matsuda et al., 2000; Osten et al.,
in the mammalian CNS is mediated by the ionotropic 2000).
glutamate receptors. Ionotropic glutamate receptors are GRIP and ABP contain multiple PDZ domains through
divided into three subtypes based on their pharmacology which they can form homo- and heteromultimers (Dong
and molecular biology: a-amino-3-hydroxyl-5-methyl-4- et al., 1997; Srivastava et al., 1998; Dong et al., 1999).
isoxazolepropionate receptors (AMPARs), N-methyl-D- As well as interacting with AMPARs, GRIP and ABP also
aspartate receptors (NMDARs), and kainate receptors interact with other proteins containing the PDZ binding
(KARs; Watkins and Evans, 1981; Hollmann and Heine- motif, for example ephrin ligands and receptors (Torres
mann, 1994). AMPARs mediate the majority of low-fre- et al., 1998). Therefore, it has been hypothesized that
quency transmission at glutamatergic synapses and are they are involved in the clustering of AMPARs or other
involved in the expression of long-term potentiation PDZ-containing proteins with signaling molecules at the
(LTP) and LTD (Bliss and Collingridge, 1993; Bear and synapse, and in the trafficking of these proteins from the
Abraham, 1996; Malenka and Nicoll, 1999). Golgi apparatus to the postsynaptic membrane (Dong et
AMPARs are heteromeric assemblies made up of al., 1997; Srivastava et al., 1998; Braithwaite et al., 2000).
combinations of up to four subunits, GluR1–4, producing PICK1 was first identified as an interactor with the
receptor complexes with diverse properties. The GluR2 catalytic subunit of PKCa (Staudinger et al., 1995, 1997).
It has a single PDZ domain that can interact with PKCa
or GluR2/3. It can also dimerize via an interaction at a* To whom correspondence should be addressed (e-mail: j.t.r.isaac@
site distinct from the PDZ domain. Therefore, PICK1 canbristol.ac.uk).
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ology, Building 49, National Institute of Child Health and Human may be involved in clustering AMPARs at synapses and/
Development, National Institutes of Health, Bethesda, Maryland or the regulation of PKC dependent phosphorylation
20892.
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vartis Pharma AG, WSJ-386.7.43, CH-4002 Basel, Switzerland. Here we show that ct-GluR2/3 PDZ interactions are
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important for regulating the function of synaptic AMPARs
in hippocampal CA1 neurons. Introduction of a peptide
corresponding to the last 11 amino acids of ct-GluR2/3
(pep2-SVKI) into CA1 neurons caused a potentiation
of basal synaptic transmission in approximately one-
third of cells. In addition, it blocked LTD in all cells
tested. Application of a PKC inhibitor prevented both
the potentiation in basal transmission and the blockade
of LTD caused by pep2-SVKI. Prior induction of LTD
resulted in pep2-SVKI causing a potentiation of EPSCs
in the majority of cells. Furthermore, dedepression (i.e.,
repotentiation of a pathway that had previously received
LTD) was selectively blocked by PKC inhibitors. These
data indicate that the ct-GluR2/3 PDZ interactions regu-
late synaptic transmission at CA1 synapses in an activ-
ity- and PKC-dependent manner.
Results
Biochemical Investigation of the Effects of ct-GluR2
Peptides on the PICK1-GluR2 Interaction
To study the functional role(s) of ct-GluR2/3 PDZ interac-
tions in synaptic transmission and long-term synaptic
plasticity, we used a peptide corresponding to the last
11 amino acids of GluR2 (YNVYGIESVKI; “pep2-SVKI”
[Dev et al., 1999; Xia et al., 1999]) to disrupt ct-GluR2
PDZ interactions in neurons. It has already been shown Figure 1. The Effects of ct-GluR2 Peptides on the In Vitro Binding
that an almost identical peptide corresponding to the of ct-GluR2 to PICK1
last ten amino acids of GluR2, “GluR2-SVKI” (sequence: (a) Western blot with anti-PICK1 showing the levels of flag-PICK1
retained by GST-ct-GluR2 in the presence or absence of ct-GluR2NVYGIESVKI), blocks the GRIP-GluR2 interaction in a
peptides: no peptide control, pep2-SVKI, pep2-SVKE, pep2-EVKI.biochemical assay (Li et al., 1999). Two other peptides,
Fusion protein GST-ct-GluR2, was isolated from E. coli strain BL21.“GluR2-SVKE” (NVYGIESVKE), which contains a single
Flag-tagged PICK1 was obtained from transfected COS-7 cells.amino acid substitution in the PDZ binding motif, and GST-ct-GluR2 was bound to glutathione Sepharose beads and incu-
“GluR2-EVKI” (NVYGIEEVKI), in which serine 880 is re- bated with COS-7 cell lysate containing flag-PICK1 (that had been
placed with a glutamate, were found to be ineffective preincubated with or without peptides; in the illustrated experiment
a peptide concentration of 133 mM was used). Beads were finallyat blocking this interaction.
washed and examined by Western blotting for content of flag-PICK1.We tested the effects of the 11–amino acid equivalents
(b) Sequences of the synthetic peptides used in this study (singleof these three peptides, pep2-SVKI, pep2-SVKE, and
letter amino acid code) and the interactions that they block. pep2-pep2-EVKI on the PICK1-GluR2 interaction (Figure 1). SVKI is the sequence of the last 11 amino acids of wild-type GluR2.
Pep2-SVKI and pep2-EVKI blocked the retention of Bold underlined residues indicate differences from the wild-type
PICK1 by GST-GluR2, while pep2-SVKE had no effect. GluR2 sequence.
Thus, pep2-SVKE is an ideal control peptide for testing
ct-GluR2 PDZ interactions, and pep2-EVKI, in agree-
ment with another recent study (Chung et al., 2000), can 25–30 min . 130% of initial baseline at 0–5 min; Figure
be used to selectively block the PICK1-GluR2 inter- 2a). The increase in amplitude stabilized by z30 min
action. and persisted for the duration of recordings (up to 90
min). In the remaining pathways (63/99, 64%), no change
in EPSC amplitude was observed for the duration ofPep2-SVKI Causes an Increase in the Amplitude
of AMPAR-Mediated EPSCs in a Subset recordings (up to 100 min; Figure 2b). This increase in
EPSC amplitude in a subset of experiments was consis-of Experiments
To study the role of ct-GluR2/3 PDZ interactions in regu- tently observed with different batches of pep2-SVKI and
by different investigators. When all data were pooledlating synaptic AMPARs, we introduced ct-GluR2 pep-
tides into CA1 pyramidal cells in hippocampal slices via (increase and no increase in EPSC amplitude) there was
a significant increase in EPSC amplitude at 25–30 minthe patch electrode during whole-cell recordings. In a
first set of experiments, we studied the effects on basal compared to the first 5 min of recordings (EPSC ampli-
tude 5 134% 6 7%, p , 5 3 1024, n 5 99; Figure 2c).synaptic transmission by infusing peptides into neurons
while evoking AMPAR-mediated excitatory postsynap- We also separated and pooled the data on the basis of
whether there was an increase in amplitude (Figure 2d).tic currents (EPSCs). In the majority of experiments two
independent pathways were stimulated. When using an EPSC amplitude increased to 205% 6 15% (p , 1 3
1025, n 5 36) in the subset that exhibited the increase,intracellular solution containing pep2-SVKI (100 mM), an
increase in the amplitude of EPSCs was observed z5 while amplitude exhibited a small depression in the re-
mainder (93% 6 2%, p , 0.05, n 5 63).min after the start of the recording in 36/99 (36%) path-
ways (EPSC amplitude average over a 5 min period from This effect of pep2-SVKI on EPSC amplitude was pre-
ct-GluR2/3 PDZ Interactions and AMPAR Function
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Figure 2. Pep2-SVKI Causes an Increase in AMPAR-Mediated EPSCs in Hippocampal CA1 Neurons in a Subset of Experiments
(a) Amplitude (normalized to first 5 min) versus time (relative to the start of the recording) for a single experiment with pep2-SVKI (100 mM) in
the recording electrode showing an increase in EPSC amplitude.
(b) An example experiment with pep2-SVKI (100 mM) in the recording electrode in which no increase in EPSC amplitude was observed.
(c) Summary graph of mean amplitude versus time of all experiments with pep2-SVKI in the intracellular solution (n 5 99 pathways, 59 cells;
significant increase in EPSC amplitude when statistics performed on pathways p , 5 3 1025, or on cells [data for both pathways onto the
same cell averaged] p , 0.001).
(d) Summary graph of mean amplitude versus time for experiments with pep2-SVKI subdivided into experiments in which there was an increase
(n 5 36 pathways, 23 cells; significant increase for statistics based on pathways p , 1 3 1025, or cells p , 1 3 1025) and was not an increase
(n 5 63 pathways from 42 cells) in EPSC amplitude (N.B. in six cells, one pathway increased and the other did not). Open symbols: pathways
in which average EPSC amplitude 25–30 min . 130% baseline; closed symbols: , 130% baseline. For this and following figures, series
resistance (squares) is plotted on the same graph as EPSC amplitude. EPSC traces (average of three EPSCs, stimulus artifacts removed)
were taken at the time points indicated.
(e) Analysis of all experiments showing the proportion of pathways or cells in which EPSC amplitude increased with pep2-SVKI (“pathway
specific” indicates cells in which pep2-SVKI had different effects on the two pathways).
(f) Mean change in 1/CV2 plotted versus change in EPSC amplitude (values at 25–30 min compared to baseline of 0–5 min) for 11 of the
pathways (randomly selected) that showed an increase with pep2-SVKI.
dominantly cell rather than pathway specific (Figure 2e). rupted the interaction between ct-GluR2 and PDZ pro-
teins, the change in quantal content was very likely dueIn the majority of cells in which data from two pathways
were collected, pep2-SVKI had the same effect on both to a postsynaptic increase in the number of functional
synapses. One possibility, therefore, is that pep2-SVKIpathways (in 11/38 cells [29%] both pathways in-
creased, in 21/38 cells [55%] there was no effect), while causes the insertion of AMPARs at silent synapses pro-
ducing a postsynaptic increase in n.in only 6/38 cells (16%) the effects were pathway spe-
cific. We also performed two types of controls, interleaved
with the pep2-SVKI experiments. In one set of experi-We also performed a coefficient of variation (CV) anal-
ysis (Faber and Korn, 1991; Kullmann, 1994) on 11 of ments, an intracellular solution that lacked pep2-SVKI,
but was otherwise identical, was used (Figures 3a andthe pathways that exhibited the increase with pep2-
SVKI. This analysis showed that on average there was 3b). In the other controls, the inactive control peptide
pep2-SVKE was used (Figures 3c and 3d). There wasa large change in CV associated with the increase in
amplitude. When change in 1/CV2 was plotted versus no change in EPSC amplitude in the “no peptide” control
(107% 6 5%, p 5 0.1, n 5 51) or in the presence ofchange in EPSC amplitude, the mean value was very
close to the line of unity (1/CV2 5 194% 6 22%; EPSC pep2-SVKE (103% 6 5%, p 5 0.3, n 5 44).
Pep2-SVKI does not distinguish between the GRIP/amplitude 5 186% 6 16% n 5 11; Figure 2f), indicating
that the increase in EPSC amplitude was most likely ABP-GluR2 and PICK1-GluR2 interactions. To investi-
gate which interacting protein was important for thisdue to a change in quantal content. Quantal content is
composed of probability of release (Pr) and number of effect, we used pep2-EVKI, which blocks PICK1 but not
GRIP/ABP binding to GluR2/3 (Figure 1; see also Li etfunctional synapses (n). Since the peptide was intro-
duced into the postsynaptic cell and specifically dis- al., 1999; Chung et al., 2000). Pep2-EVKI (100 mM) had
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Figure 3. EPSCs Are Unaffected by a Control Peptide or a PICK1 Selective Peptide
Amplitude versus time plots for: (a) a single experiment without peptide, (b) summary graph of experiments without peptide (n 5 51 pathways,
26 cells; no significant change in EPSC amplitude when statistics performed on pathways p 5 0.1 or on cells p 5 0.2), (c) a single experiment
with pep2-SVKE (100 mM), (d) summary graph of experiments with pep2-SVKE (n 5 44 pathways, 24 cells; no significant change in EPSC
amplitude when statistics performed on pathways p 5 0.3 or on cells p 5 1.0), (e) an example experiment with pep2-EVKI (100 mM), and (f)
summary data for pep2-EVKI (n 5 44 pathways, 22 cells; no significant change in EPSC amplitude when statistics performed on pathways
p 5 0.6 or on cells p 5 0.6).
no effect on basal synaptic transmission (103% 6 6%, domain (Davis et al., 1989; Wilkinson et al., 1993), on
basal synaptic transmission using extracellular field po-p 5 0.6, n 5 44; Figures 3e and 3f) when included in
the intracellular solution. This could suggest that PICK1 tential recordings. Neither inhibitor had any effect on
basal transmission in these experiments (data notis not involved in this regulation of AMPARs and that
rather it is the GRIP/ABP-GluR2/3 interaction that is shown). These data suggest that during basal transmis-
sion AMPAR function at these synapses is not main-important. Alternatively, it could mean that the GRIP/
ABP and PICK1 are both involved but that they are tained by constitutive PKC activity. This is in agreement
with other studies in which it was found that inhibitorsinterchangeable.
acting on the regulatory domain of PKC did not affect
basal AMPAR-mediated synaptic transmission (e.g.,PKC Activity Is Required for the Pep2-SVKI Effect
on Basal Synaptic Transmission Malinow et al., 1988; Reymann et al., 1988; Colley et al.,
1990; Bortolotto and Collingridge, 2000).The experiments described above show that disruption
of ct-GluR2/3 PDZ interactions causes an increase in We then investigated the effects of infusing pep2-
SVKI into neurons while PKC was blocked. In the pres-AMPAR-mediated synaptic transmission in a subset of
cells. The extreme C terminus of GluR2/3 contains a ence of bath applied BIS (1 mM), there was no increase
in EPSC amplitude with pep2-SVKI (103% 6 7%, p 5 0.6,PKC phosphorylation consensus sequence (-SVK-) and
the serine in this region (Ser880) is phosphorylated by n 5 34; Figures 4c and 4d), even though in interleaved
experiments with pep2-SVKI alone, increases in EPSCPKC (Matsuda et al., 1999; Chung et al., 2000; Matsuda
et al., 2000). Therefore, we investigated the involvement amplitude were still consistently observed in approxi-
mately one third of experiments (data included in Figureof PKC in the effects of blocking ct-GluR2/3 PDZ interac-
tions. First, we tested whether PKC activity is important 2). These data suggest that a PKC-dependent process
is responsible for the increase in EPSC amplitude ob-for basal transmission under control conditions. Bath
application of the selective PKC inhibitor bisindolylma- served when ct-GluR2/3 PDZ interactions are disrupted.
leimide I (BIS, 1 mM), which acts on the regulatory domain
of PKC (Toullec et al., 1991; Nishizuka, 1995), had no Pep2-SVKI Prevents the Expression of LTD
Previous studies have demonstrated a role for theeffect on basal transmission in control cells (102% 6
4%, p 5 0.6, n 5 56; Figures 4a and 4b). We also tested GluR2-NSF interaction in the expression of LTD (Lu¨scher
et al., 1999; Lu¨thi et al., 1999). Therefore, we investigatedBIS (1 mM) and another highly specific PKC inhibitor,
Ro-31-8220 (1 mM), which also acts on the regulatory whether the ct-GluR2/3 PDZ interactions are also in-
ct-GluR2/3 PDZ Interactions and AMPAR Function
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Figure 4. Bath Application of the PKC Inhibitor BIS Blocks the Increase in EPSC Amplitude Caused by Pep2-SVKI
(a) Amplitude versus time plot for an example experiment in which BIS (1 mM) was applied after 10 min of baseline recording without peptide
in the recording electrode.
(b) Summary graph of these experiments (n 5 56 pathways, 28 cells; no significant change in EPSC amplitude when statistics performed on
pathways p 5 0.6 or on cells p 5 0.6).
(c) Example experiment with pep2-SVKI in the intracellular solution in the presence of bath applied BIS (1 mM).
(d) Summary graph of these pep2-SVKI experiments in the presence of BIS (n 5 34 pathways, 17 cells; no significant change in EPSC amplitude
when statistics performed on pathways p 5 0.6 or on cells p 5 0.8).
volved in LTD. Whole-cell recordings were made, and was effective at blocking LTD in all pathways. These
data suggest that ct-GluR2/3 PDZ interactions are im-two independent pathways were monitored. Following
at least 30 min of whole-cell dialysis, an LTD induction portant both for the regulation of basal transmission
and LTD.protocol of 300 stimuli at 1 Hz paired with a holding
potential of 240 mV was applied to one pathway (test
pathway). This protocol has previously been shown to PKC Activity Is Required for the Pep2-SVKI
Block of LTDinduce homosynaptic NMDAR-dependent LTD (Hjelm-
stad et al., 1997; Lu¨thi et al., 1999). In the absence of We investigated whether there was an involvement of
PKC in the pep2-SVKI block of LTD, since the PKCpeptide, LTD was reliably induced in the test pathway
(EPSC amplitude 25–30 min after LTD induction 5 inhibitor, BIS blocked the effects of pep2-SVKI on basal
transmission. In the presence of bath applied BIS (163% 6 6% of pre-LTD baseline [0–10 min before induc-
tion], p , 0.005 versus pre-LTD baseline, n 5 5; Figure mM), pep2-SVKI did not block LTD (73% 6 4%, p , 5 3
1025 versus pre-LTD baseline, n 5 11; p , 0.005 versus5a). However, in interleaved experiments, pep2-SVKI
blocked LTD in all experiments, leaving only a transient pep2-SVKI LTD; Figures 6e and 6f). This suggests that,
similar to the effects on basal transmission, PKC activitydepression in the test pathway (95% 6 6%, p 5 0.4
versus pre-LTD baseline, n 5 10; Figures 5c and 5d). is required for the block of LTD to occur when ct-GluR2/3
PDZ interactions are disrupted by pep2-SVKI.The effect of pep2-SVKI on LTD was independent of
whether or not it caused an increase in basal EPSC
amplitude. Importantly, the control peptide pep2-SVKE Prior Induction of LTD Modifies the Effects
of Pep2-SVKI on Basal Transmissiondid not block LTD (73% 6 9%, p , 0.05 versus pre-LTD
baseline, n 5 10; Figure 5b). We also tested whether We reasoned that the block of LTD by pep2-SVKI might
be because LTD primes synapses to undergo the in-pep2-EVKI, which selectively blocks the PICK1 interac-
tion, prevented LTD. In the presence of pep2-EVKI, LTD crease in transmission in the presence of the peptide. To
test this idea, we performed two pathway experimentswas also reliably induced (81% 6 3%, p , 0.001 versus
pre-LTD baseline, n 5 8; Figure 5b). Thus, pep2-SVKI, using extracellular recordings in which LTD was induced
in one pathway by applying a low-frequency stimulationbut neither pep2-SVKE nor pep2-EVKI, blocked LTD.
However, unlike with basal transmission, pep2-SVKI protocol (LFS; 900 stimuli, 1Hz; Figure 6a). This pro-
Neuron
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Figure 5. Pep2-SVKI Blocks LTD in a PKC-Dependent Manner
(a) EPSC amplitude (percent of pre-LTD baseline collected for 10 min before induction) versus time plot for an example LTD experiment with
no peptide. For this figure, the paired pathway is represented by closed symbols and control pathway by open symbols. The black bar
represents the pairing protocol for induction of LTD.
(b) Summary graph of pooled control LTD experiments (n 5 23) either with no peptide (n 5 5), with the inactive control peptide pep2-SVKE
(n 5 10) or pep2-EVKI (n 5 8; all controls were interleaved with pep2-SVKI LTD experiments).
(c) Example LTD experiment with pep2-SVKI in the recording electrode.
(d) Summary graph of the pep2-SVKI LTD experiments (n 5 18 at 20 min, n 5 10 at 30 min; 8 cells were lost between 20 and 30 min).
(e) EPSC amplitude versus time for an example LTD experiment with pep2-SVKI in the recording electrode in the presence of bath applied
BIS (1 mM).
(f) Summary graph of LTD experiments with pep2-SVKI and BIS (n 5 12 at 20 min, n 5 11 at 30 min; 1 cell lost between 20 and 30 min).
duced a homosynaptic depression in fEPSP slope to increase in amplitude in the majority of experiments.
The lack of pathway specificity of this particular effect71% 6 4% of baseline (n 5 8). After induction of LTD,
a whole-cell recording was obtained from a neuron in suggests that the induction of LTD causes the produc-
tion of some signal that can diffuse to other noncondi-the same region of the slice, and EPSCs were evoked
at the same two pathways using the same or lower tioned synapses causing the heterosynaptic effects.
Prior induction of LTD also had another effect. Thestimulus intensity. Under these conditions, the fre-
quency with which pep2-SVKI caused an increase in onset of the increase in EPSC amplitude caused by
pep2-SVKI was much more rapid following LTD induc-transmission was greatly increased (Figures 6b–6d).
Surprisingly, this effect was not restricted to the path- tion, compared to nonconditioned slices that showed a
characteristic onset delay of z5 min (Figure 6c). Thisway that had previously received LTD, but occurred in
both the conditioned and nonconditioned pathways. suggests that prior induction of LTD (i.e., in the absence
of pep2-SVKI) primes synapses both homo- and hetero-Since these experiments were performed at a higher
temperature to facilitate the induction of LTD using LFS synaptically so that subsequent disruption of the ct-
GluR2 PDZ interactions causes a very rapid insertion of(288C–308C rather than room temperature), we also
tested the effect of pep2-SVKI at this temperature on receptors.
slices in which LTD had not been induced (“noncondi-
tioned” slices). Similar to experiments performed at A Model for the Regulation of AMPAR Insertion
by ct-GluR2 PDZ Interactionsroom temperature, pep2-SVKI caused an increase in
EPSC amplitude only in a subset of experiments (Figures Figure 7 shows a hypothesis based on the data pre-
sented so far, for the mechanism by which ct-GluR2/36c and 6d), although the kinetics of the increase exhib-
ited a somewhat different profile, presumably due to PDZ interactions regulate AMPARs at CA1 synapses. In
this model, there are two intracellular pools of AMPARsthe higher temperature. These data suggest that prior
induction of LTD primes synapses or receptors so that at synapses: AMPARs containing GluR2 phosphorylated
at serine 880 in a “constitutive pool,” which rapidly anddisruption of the ct-GluR2 PDZ interactions causes an
ct-GluR2/3 PDZ Interactions and AMPAR Function
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Figure 6. Prior Induction of LTD Causes EPSCs to Increase in the Majority of Pathways in the Presence of Pep2-SVKI
(a) Summary data from extracellular recordings for two pathway experiments in which LTD was induced in one pathway (closed circles; open
circles control path; n 5 8). Field EPSPs from an example experiment, collected at the times indicated for the LTD pathway.
(b) Pooled data (n 5 9) of EPSC amplitude versus time for two pathway experiments in which pep2-SVKI was introduced into cells in slices
in which LTD had been previously induced using extracellular recordings. EPSCs were evoked at the same two pathways (closed circles
conditioned path, open circles control path; these experiments performed at 288C–308C).
(c) Summary data for all experiments in which pep2-SVKI was introduced into cells following LTD induction (closed circles, conditioned and
nonconditioned pathway data pooled; n 5 18 pathways from nine cells), effects of pep2-SVKI in nonconditioned slices (closed triangles; at
288C–308C; n 5 14 pathways from seven cells) and pep2-SVKI in nonconditioned slices at room temperature (gray circles; data replotted from
Figure 2c). Inset: data for effects of pep2-SVKI for prior induction of LTD (circles) and nonconditioned slices at 288C–308C (triangles) shown
on an expanded time scale to illustrate the difference in the onset of the increase in EPSC amplitude for the two data sets. For this inset,
data are replotted as percent change from baseline (i.e., no change 5 0%) and nonconditioned slice data is scaled to the peak of the EPSC
amplitude increase of the conditioned slice data (at 10–15 min).
(d) Summary data showing (gray bars) the frequency of observing the increase in EPSC amplitude for the three different conditions and
(hatched bars) the lack of pathway specificity for pep2-SVKI following prior induction of LTD.
constitutively recycle via the NSF-GluR2-dependent Dedepression Is Blocked by PKC Inhibitors
This model predicts that one form of LTP, dedepressionmechanism previously described (Nishimune et al.,
1998; Osten et al., 1998; Song et al., 1998; Lu¨scher et (DD; LTP following prior induction of LTD) should be
PKC dependent. Lee et al. (2000) have recently reportedal., 1999; Lu¨thi et al., 1999; Noel et al., 1999). AMPARs
that contain GluR2 not phosphorylated at serine 880 are that DD is blocked by a PKA inhibitor; however, there
was a component of DD that was insensitive to thisin a “regulated pool” and require PKC phosphorylation
of this site to enter the constitutive pool and be inserted inhibitor. To investigate the possible involvement of PKC
in DD, we used KN-62 (10 mM) and KT5720 (1 mM) tointo the membrane. In this scheme, proteins interacting
at the ct-GluR2/3 PDZ binding motif bind to nonphos- block CaMKII and PKA, respectively. Under these condi-
tions in two pathway field potential experiments, LTPphorylated GluR2/3 and act as an “insertion clamp”;
their binding blocks PKC-dependent phosphorylation of of naı¨ve pathway was fully blocked; however, the same
induction protocol caused DD of the input that had pre-serine 880, thus preventing the receptors entering the
constitutive pool. viously undergone LTD (Figure 8a). DD, however, was
Neuron
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Figure 7. A Model for the Regulation of AMPARs by ct-GluR2/3 PDZ Interacting Proteins
PKC-dependent phosphorylation of ct-GluR2/3 at serine 880 causes insertion of AMPARs into the postsynaptic membrane. This process is
regulated by ct-GluR2/3 PDZ interactions, which prevent the PKC-dependent phosphorylation.
blocked in a fully reversible manner when a PKC inhibitor corresponding to the last ten amino acids of GluR2, was
shown to block GRIP-GluR2 interactions (Li et al., 1999).(n 5 9), either BIS (1 mM) or Ro-31-8820 (1 mM), was
coapplied with KN-62 and KT5720 (Figures 8b and 8c). Since a single amino acid substitution (-SVKI to -SVKE)
renders the peptide inactive at blocking both PICK1Therefore, these data show that DD is PKC dependent
and suggests that the ct-GluR2 PDZ interactions can (Figure 1; Chung et al., 2000) and GRIP/ABP (Li et al.,
1999) interactions, and since pep2 -SVKE peptide isbe disrupted physiologically during synaptic activity.
inactive in the physiological experiments, the effects of
pep2-SVKI can be specifically attributed to the disrup-Discussion
tion of ct-GluR2/3 PDZ interactions.
A recent study has implicated a ct-GluR1 PDZ interac-In this study, we have shown that ct-GluR2/3 PDZ inter-
tion in the regulated insertion of GluR1 homomers inactions are functionally important for regulating synaptic
hippocampal neurons (Hayashi et al., 2000) presumablyAMPARs in hippocampal CA1 neurons. Disruption of
involving the GluR1-SAP97 interaction (Leonard et al.,these interactions, with an 11–amino acid peptide corre-
1998). One possibility, therefore, is that the effects ofsponding to ct-GluR2/3 (pep2-SVKI), caused an in-
pep2-SVKI might involve the blockade of this interac-crease in basal AMPAR-mediated transmission in ap-
tion. However, this is unlikely because SAP97 does notproximately a third of cells and blocked the generation
interact with either GluR2 or GluR3 (Leonard et al., 1998)of LTD in all cells. These effects were not observed with
and the PDZ binding domain on GluR1 has a differentcontrol peptides and were blocked by a PKC inhibitor.
sequence to pep2-SVKI. Furthermore, Hayashi and co-Following prior induction of LTD, pep2-SVKI caused an
workers found that the GluR1 PDZ interaction was nec-increase in basal transmission at both conditioned and
essary for insertion, and therefore if blocked this wouldcontrol pathways in most experiments. Finally, we dem-
cause a depression in EPSC amplitude, contrary to theonstrated that DD was blocked by PKC inhibitors. We
results in the present study.propose a model in which ct-GluR2 PDZ proteins are
One potential problem with the peptides used in thisinvolved in the expression of LTD. In addition, we pro-
study is that there is a possibility that they could act aspose that these interactions are involved in a form of
competitive inhibitors of PKC. However, in our study allLTP, by regulating the PKC-dependent insertion of
the effects of pep2-SVKI were blocked by a PKC inhibi-AMPARs so that DD can be triggered by an appropriate
tor, strongly suggesting that pep2-SVKI was not itselfphysiological stimulus.
acting as a PKC inhibitor. Furthermore, the effects of
the ten amino acid ct-GluR2 peptides on AMPARs inSpecificity of the Interaction
spinal cord neurons have been shown not to be dueUsing a biochemical assay, we have shown that pep2-
to direct inhibition of PKC (Li et al., 1999). A relatedSVKI blocks the PICK1-GluR2 interaction, and in a previ-
ous study an almost identical peptide, “GluR2-SVKI,” consideration is that pep2-SVKI needs to be phosphory-
ct-GluR2/3 PDZ Interactions and AMPAR Function
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Figure 8. Dedepression Is Blocked by PKC Inhibitors
(a) Summary data of two pathway field potential experiments (n 5 4) showing fEPSP slope (percent baseline) versus time in which an LTP
induction protocol was applied, in the presence of KN-62 (10 mM; CaMKII inhibitor) and KT5720 (1 mM; PKA inhibitor), to a naı¨ve pathway
(open circles) and a pathway in which LTD had previously been induced (closed circles). Representative traces from a single experiment
shown, taken at the times indicated.
(b) Summary data for experiments similar to those in (a) in which an LTP induction protocol was applied to the pathway that had undergone
LTD in the presence of KN-62, KT5720, and BIS (1 mM; PKC inhibitor; n 5 5).
(c) Summary data for experiments in which an LTP induction protocol was applied, in the presence of KN-62, KT5720, and Ro-31-8220 (1
mM; PKC inhibitor; n 5 4), to the pathway that had undergone LTD.
lated before it becomes active and that the PKC inhibi- al., 2000; Man et al., 2000) and cerebellar neurons (Liu
and Cull-Candy, 2000; Matsuda et al., 2000; Wang andtors work in our study by blocking this phosphorylation
rather than that of an endogenous substrate such as Linden, 2000). The finding that the increase in basal
transmission with pep2-SVKI is associated with a largeGluR2. Although we cannot completely exclude this pos-
sibility, evidence against this is provided by the lack of change in CV is consistent with this possibility and indi-
cates that receptors may be preferentially inserted ateffect of pep2-EVKI in which the serine is substituted
by a glutamate, a manipulation equivalent to the phos- silent synapses.
One surprising finding was that the effects of pep2-phorylation of serine 880 (at least with respect to pre-
venting the interaction between GRIP/ABP and GluR2). SVKI were primarily cell specific rather than pathway
specific. Further evidence for a cell-specific effect was
provided by the experiments in which LTD was inducedFunctional Effects of Pep2-SVKI
prior to introducing the peptide into cells. Under theseon AMPAR-Mediated EPSCs
conditions, the incidence of the increase in transmissionThere are a number of possible mechanisms by which
with pep2-SVKI was greatly increased, but this occurredpep2-SVKI could cause the enhancement of synaptic
at both the LTD and control pathways. This suggeststransmission. Given that we use a postsynaptically in-
that some signal is generated at the synapses that un-jected peptide, it is highly unlikely that the effects are
derwent LTD, which diffuses intracellularly to other syn-presynaptic or via glutamate transporter mechanisms.
apses in the cell. This signal could be mobile PKC regu-The possible postsynaptic mechanisms are: an increase
lated AMPARs perhaps associated with PICK (Chung etin single channel conductance (g), an increase in the
al., 2000) or a second messenger such as release ofprobability of the channel opening on binding ligand
Ca21 from intracellular stores that stimulates the PKC-(Popen), a change in channel kinetics or an increase in the
dependent regulation of AMPARs (B. Maher and P. T.number of receptors available to bind L-glutamate. We
Kelly, 2000, Soc. Neurosci. Abstr. 26, 38.17).think the latter is a plausible explanation for the changes
in synaptic transmission we observe given the body of
evidence that AMPARs can be rapidly targeted to and PKC Modulation of AMPAR Function
There is considerable evidence for the PKC-dependentremoved from the postsynaptic membrane of hippo-
campal neurons (Nishimune et al., 1998; Song et al., modulation of AMPAR function at synapses. A number
of studies have provided support for a role for PKC in1998; Carroll et al., 1999; Lu¨scher et al., 1999; Lu¨thi et
al., 1999; Noel et al., 1999; Shi et al., 1999; Hayashi et LTP (e.g., Lovinger et al., 1987; Malinow et al., 1988;
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Reymann et al., 1988; Colley et al., 1990; Reymann et regulates the insertion of AMPARs; however, this too
would have to be regulated by the ct-GluR2/3 PDZ inter-al., 1990; Klann et al., 1991; Wang and Feng, 1992; Sack-
actions. Our model is consistent with the lack of effect oftor et al., 1993; Hvalby et al., 1994; Osten et al., 1996);
the peptide that selectively blocks the PICK1 interactionhowever, the conclusions of some of these studies have
(pep2-EVKI) since GRIP/ABP functions to prevent un-been challenged based on the specificity of the inhibi-
regulated reinsertion. The model is also consistent withtors used (Muller et al., 1992; Lopez-Molina et al., 1993;
the well-established role for phosphatases in the ex-Roberson et al., 1996). Indeed, recently, we have pro-
pression of hippocampal NMDAR-dependent LTD (Mul-vided evidence that potent PKC inhibitors, including Ro-
key et al., 1993; Bear and Abraham, 1996). The lack of31-8220 that was used in the present study, have no
input specificity in the actions of pep2-SVKI may beeffect on LTP induction in the CA1 region of adult rat
due either to the mobility of the proportion of AMPARshippocampus (Bortolotto and Collingridge, 2000). How-
associated with PICK or some other diffusible signalever, it is possible that there is a developmental regula-
released from synapses that have undergone LTD. Thetion of a PKC-dependent mechanism for LTP, and this
input specificity of LTD and DD can be ascribed to thecould explain some of these conflicting findings.
localized activation of phosphatases and kinases, re-PKC does not appear to be involved for the induction
spectively, provided by the NMDAR-mediated Ca21of NMDAR-dependent LTD (Oliet et al., 1997), but there
influx.is evidence that the constitutively active catalytic frag-
Our data are not consistent with the idea that GRIP/ment of PKCz (PKMz) is involved in its expression (Hra-
ABP function simply to anchor AMPARs once they arebetova and Sacktor, 1996). In CA1 neurons, PKC activa-
inserted in the postsynaptic membrane (Dong et al.,tors cause an increase in both the amplitude and
1997; Srivastava et al., 1998; Osten et al., 2000). If thisfrequency of mEPSCs (Parfitt and Madison, 1993; Wang
were the case, pep2-SVKI would be expected to causeet al., 1994; Carroll et al., 1998). In spinal neurons, PKC
a reduction in AMPAR-mediated EPSCs, rather than thepotentiates synaptic transmission and this is dependent
increase or no change that was observed. However,upon ct-GluR2/3 PDZ interactions (Li et al., 1999). There-
our results do not exclude a role for GRIP/ABP in thefore, under certain but not all experimental conditions,
stabilization at the synaptic membrane of a more slowlyPKC appears to be involved in the regulation of AMPAR
recycling pool of AMPARs that would not be detectedfunction both during basal transmission and during syn-
over the time course of the present experiments. Indeed,aptic plasticity. The precise mechanisms, however, for
previous experiments from our and other groups, usingthe PKC-dependent regulation of AMPAR function are
peptides that block the NSF-GluR2 interaction, suggestnot known.
the existence of just such a slowly recycling pool atIn the present study, we used the PKC inhibitors BIS
these synapses (Nishimune et al., 1998; Song et al.,and Ro-31-8220, at a concentration that blocks several
1998; Lu¨scher et al., 1999; Lu¨thi et al., 1999). An addi-PKC isoforms, including PKCa (Davis et al., 1989; Toul-
tional role, such as this for the GRIP/ABP-GluR2 interac-lec et al., 1991; Wilkinson et al., 1993). We found no
tion, could explain recent evidence in cultured neuronsinvolvement of these PKC isoforms in maintaining basal
that this interaction is important for the surface accumu-transmission; however, PKC activity was important for
lation of GluR2 (Osten et al., 2000). Furthermore, itthe potentiation caused by pep2-SVKI and in DD. There-
should be noted that in this latter study, effects on thefore, our data suggests that PKC is involved in the regu-
trafficking of GluR2 were observed when the extremelated insertion of AMPARs at synapses.
C terminus was removed or serine 880 was mutated.
These are manipulations that, in addition to preventing
PKC-Dependent AMPAR Insertion Regulated GRIP/ABP binding, also prevent PKC phosphorylation
by ct-GluR2 PDZ Interactions of ct-GluR2, an event that may be critically important
A key feature of our model is that the binding of PDZ for the regulation of the surface expression of receptors
proteins to ct-GluR2/3 regulates the insertion of recep- as suggested by the data in the present study.
tors. We hypothesize that during LTD, AMPARs are inter- Our model can explain the finding in spinal cord neu-
nalized (Carroll et al., 1999; Lu¨scher et al., 1999; Lu¨thi rons that the PKC-dependent insertion of AMPARs at
et al., 1999), and these internalized receptors bind to silent synapses requires ct-GluR2 PDZ interactions (Li
GRIP/ABP, which anchors them at the subsynaptic et al., 1999). This preparation is somewhat different from
membrane (Dong et al., 1997; Srivastava et al., 1998), hippocampal slices in that there appears to be very
preventing their rapid reinsertion. However, a proportion little basal PKC activity since PKC had to be activated
of receptors can associate with PICK1 present in spines pharmacologically before effects were observed. One
(Xia et al., 1999) and in this configuration may be mobile possibility, therefore, is that AMPARs ready for insertion
(Chung et al., 2000). The role of PICK1 is likely to be in are localized to silent synapses by being anchored to
targeting PKC to GluR2. During DD, AMPARs dissociate GRIP/ABP at the subsynaptic membrane. Blocking this
from PICK1 or GRIP/ABP and PKC phosphorylates ser- anchoring with the introduction of a peptide could cause
ine 880. This prevents rebinding to GRIP/ABP (Chung receptors to diffuse away from silent synapses before
et al., 2000) and allows insertion of receptors. the PKC activator was applied, thus removing the sub-
Although we have proposed that the phosphorylation strate for PKC-dependent insertion. Thus, the peptide
state of serine 880 is the critical step for signaling would prevent the PKC-driven insertion of new recep-
AMPAR internalization/insertion, we do not, however, tors. The lack of effect of the peptide on basal transmis-
have any direct evidence that the PKC-dependent pro- sion observed in this study could reflect the lack of basal
cess is the phosphorylation of this site. It is possible PKC activity.
Different mechanisms involving PKC and AMPA re-that a different PKC-dependent phosphorylation step
ct-GluR2/3 PDZ Interactions and AMPAR Function
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ceptor movement clearly exist in other neurons, for ex- Conclusion
The interactions of PDZ proteins with ct-GluR2 are likelyample in the cerebellum (Matsuda et al., 2000), and may
to have multiple roles and are much more dynamic inalso coexist in hippocampal neurons (Chung et al.,
regulating synaptic transmission than was originally2000). Our results are, however, consistent with the
thought. They provide an extra level of complexity forwell-established role of kinases and phosphatases in
interactions between the protein scaffold and the signalNMDAR-dependent homosynaptic LTD and LTP in the
transduction pathways present at the synapse, and it ishippocampus (Bliss and Collingridge, 1993; Bear and
this interplay that is important for regulating AMPARAbraham, 1996; Malenka and Nicoll, 1999).
number at hippocampal synapses during basal trans-
mission and synaptic plasticity.
Implications for Synaptic Plasticity
Experimental Proceduresand Development
One implication of the model presented in the present GST Pulldown Assays
study is that GluR2/3 PDZ interactions are an essential GST was fused to ct-GluR2 by subcloning into pGEX-4T-1 (Phar-
macia, Uppsala, Sweden). A flag-tagged PICK1 was prepared usingcomponent of the mechanism for the maintenance and
PCR, with the tag introduced at the N terminus of PICK1 and sub-expression of NMDAR-dependent LTD by preventing
cloned into pCIneo (Promega, Madison, WI). COS-7 cells were trans-the constitutive reinsertion of AMPARs removed during
fected with flag-PICK1 using LipofectAMINE/PLUS (GIBCO Life
LTD. This model does not exclude additional mecha- Tech., Geithersburg, MD) and used 48 hr after transfection. Esche-
nisms for LTD involving, for example, the dephosphory- richia coli strain BL21 was transformed with GST-ct-GluR2 as de-
scribed by manufacturer’s protocol (Pharmacia). Sonicates of BL21lation of GluR1 (Kameyama et al., 1998; Lee et al., 1998)
expressing GST-ct-GluR2 and lysates of COS-7 cells transientlyperhaps causing a reduction in Popen (Banke et al., 2000).
expressing flag-PICK1 were prepared in PTxE buffer (PBS, 1% TritonA second implication is that PKC is involved in the inser-
X-100, 0.1 mM EDTA [pH 7.4]), and GST pulldown assays were
tion of AMPARs and that this process is important for performed essentially as described previously (Dev et al., 1999).
the mechanism of DD. A recent study provided evidence Breifly, 1 ml GST-ct-GluR2 lysates (z1 mg/1 ml total protein) were
that PKA was also involved in DD; however, it was not coupled to 20 ml gluthathione Sepharose 4B (Pharmacia) in the
presence of 1 mg/ml bovine serum albumin (BSA, Sigma) for 2 hrfully blocked by a PKA inhibitor suggesting an additional
at 48C. Meanwhile, 100 ml flag-PICK1 was incubated with or withoutmechanism (Lee et al., 2000). In the present study, we
peptide (100 or 133 mM final concentration) for 2 hr at 48C. The
found that DD was fully blocked by PKC inhibitors. One coupled Sepharose was then washed with 33 1 ml aliquots of PTx
difference between the two studies is the age of the buffer (PBS, 0.1% Triton X-100 [pH 7.4]). The pellets were resus-
animals from which the slices were prepared; we used pended in 200 ml PTxE supplemented with 2 mg BSA and 300 ml
flag-PICK1 6 peptide mixture (80 mM final) was added. After incuba-12- to 16-day-old animals and Lee et al. (2000) used 21-
tion for 2 hr at 48C, all samples were washed, denatured, and thento 30-day-old animals. This suggests that both PKC-
separated by electrophoresis on 9% SDS-polyacrylamide gelsand PKA-dependent mechanisms contribute to DD but
(SDS-PAGE). The primary and secondary antibodies used for West-
that there is a developmental regulation of the relative ern blotting were the affinity-purified anti-PICK-rabbit antibody
contributions of the two mechanisms. raised against peptide containing the residues 2–31 of rat PICK1
and the alkaline phosphatase-conjugated goat anti-rabbit IgG (Pro-A number of other observations from the present and
mega), respectively.other studies suggest that this PKC mechanism may be
regulated during development. We found an increase in
Electrophysiology
EPSC amplitude with pep2-SVKI in a third of experi- Transverse hippocampal slices (400 mm thick) were prepared from
ments, and this is very similar to the observed incidence rat pups (12–16 days old) using standard techniques (Nishimune et
al., 1998; Lu¨thi et al., 1999). The extracellular solution was as followsof silent synapses in animals of this age (Isaac et al.,
(mM): 124 NaCl, 3 KCl, 1.25 NaHPO4, 26 NaHCO3, 2.5 CaCl2, 1.31995; Liao et al., 1995), which is highly developmentally
MgSO4, 15 glucose, saturated with 95% O2/5% CO2. For extracellularregulated (Durand et al., 1996). Pep2-SVKI caused an
recordings, field EPSPs were recorded at a temperature of 288C–
increase in all experiments when NMDAR-dependent 308C with an electrode placed in the stratum radiatum of CA1 as
LTD was induced, and this form of LTD is prevalent in previously described (Bortolotto and Collingridge, 2000). Two inde-
young animals (Bear and Abraham, 1996). Interestingly, pendent pathways were alternately stimulated at a frequency of
0.033–0.1 Hz. LTD was induced by 900 stimuli at 1 Hz (Dudek andat this age, LTP in approximately a third of experiments
Bear, 1992; Mulkey and Malenka, 1992), LTP and DD was inducedis due to an increase in the number of activated recep-
by a single tetanus of 100 Hz, 1s at test intensity. Whole-cell patch-tors, whereas it involves an increase in single channel
clamp recordings were made from CA1 pyramidal neurons using
conductance in the remainder (Benke et al., 1998). All electrodes (2–6 MV) containing the following intracellular solution
this suggests that, in 2-week-old hippocampus, approx- (mM): 135 CsMeSO4, 8 NaCl, 10 HEPES, 0.5 EGTA, 4 Mg-ATP, 0.3
Na-GTP, 5 QX-314 (pH 7.2), 285 mOsm. Whole-cell recordings wereimately a third of synapses, in primarily a cell- rather
performed in the presence of picrotoxin (0.05 mM) in the extracellularthan pathway-specific manner, have AMPARs available
solution. The majority of recordings were performed at room temper-for PKC-dependent insertion. Taken together with the
ature except for the prior induction of LTD and associated controls
results from the CV analysis, one possibility is therefore in which 288C–308C was used. The intracellular solution also con-
that AMPARs are preferentially inserted at silent syn- tained the protease inhibitors bestatin (100 mM), leupeptin (100 mM),
and pepstatin A (100 mM). For the peptide experiments, peptidesapses in response to the appropriate physiological stim-
were dissolved in the intracellular solution at a concentration of 100ulus. Induction of NMADR-dependent LTD produces si-
mM. All solutions were checked to ensure that the pH was 7.2 andlent synapses (Lu¨thi et al., 1999) and, therefore, primes
osmolarity was 285 mOsm and were then aliquoted and stored at
synapses to enable them to utilize this mechanism. De-
2808C. On the day of the experiment, aliquots were thawed on ice
velopment may regulate this mechanism so that it is and subsequently kept on ice. EPSCs, recorded at a holding poten-
tial of 270 mV, were evoked by electrical stimulation of Schafferless easy to access in older animals.
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collateral-commissural axons at a frequency of 0.1 Hz using bipolar protein kinase C blocks two components of LTP persistence leaving
initial potentiation intact. J. Neurosci. 10, 3353–3360.stimulating electrodes placed in the stratum radiatum. For the ma-
jority of experiments, two pathways onto the same cell were alter- Davis, P.D., Hill, C.H., Keech, E., Lawton, G., Nixon, J.S., Sedgwick,
nately stimulated. For the induction of LTD using whole-cell re- A.D., Wadsworth, J., Westmacott, D., and Wilkinson, S.E. (1989).
cordings, EPSCs from two pathways were collected, and LTD was Potent selective inhibitors of protein kinase C. FEBS Lett. 259,
induced with a protocol of 300 stimuli at 1 Hz paired with a holding 61–63.
potential of 240 mV (Hjelmstad et al., 1997; Lu¨thi et al., 1999) applied
Dev, K.K., Nishimune, A., Henley, J.M., and Nakanishi, S. (1999). The
to one pathway (test pathway). For these LTD experiments, re-
protein kinase Ca binding protein PICK1 interacts with short but
cordings were maintained for at least 30 min before the induction
not long form alternative splice variants of AMPA receptor subunits.
protocol was applied to allow the peptide-containing intracellular
Neuropharmacology 38, 635–644.
solution to fully dialyze the cell. Data were recorded using an Axo-
Dong, H., O’Brien, R.J., Fung, E.T., Lanahan, A.A., Worley, P.F., andpatch 200-B amplifier, filtered at 5 kHz, digitized at 10 kHz and
Huganir, R.L. (1997). GRIP: a synaptic PDZ-containing protein thatstored on computer. EPSC amplitude, series resistance, input resis-
interacts with AMPA receptors. Nature 386, 279–284.tance, and DC were analyzed and displayed online using the LTP
Dong, H., Zhang, P., Song, I., Petralia, R.S., Liao, D., and Huganir,program (http://www.ltp-program.com). Series resistance was cal-
R.L. (1999). Characterisation of the glutamate receptor-interactingculated by estimating the peak of the unfiltered whole-cell capaci-
proteins GRIP1 and GRIP2. J. Neurosci. 19, 6930–6941.tance transient in response to a 2 mV step (electrode capacitance
was compensated for while in cell-attached mode). CV of EPSC Dudek, S.M., and Bear, M.F. (1992). Homosynaptic long-term de-
amplitude was calculated as SD/mean, and a value obtained for the pression in area CA1 of hippocampus and effects of N-methyl-D-
epoch at 0–5 min was compared to the value at 25–30 min. All aspartate receptor blockade. Proc. Natl. Acad. Sci. USA. 89, 4363–
numbers of observations reported represent number of pathways 4367.
unless stated otherwise. All data are represented as percent of
Durand, G.M., Kovalchuk, Y., and Konnerth, A. (1996). Long-term
baseline (100% is no change) 6 SEM. Statistical significance was
potentiation and functional synapse induction in developing hippo-
assessed using the Student’s t test.
campus. Nature 381, 71–75.
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